RA CAPITAL MANAGEMENT, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for 4D MOLECULAR THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (FDMT)

Filing Manager: RA CAPITAL MANAGEMENT, L.P.
Reporting Manager: RA Capital Management, L.P.
Security: 4D MOLECULAR THERAPEUTICS, INC. Common Stock, $0.0001 par value per share
Symbol: FDMT
Shares outstanding: 46,109,768 shares
Disclosed Ownership: 4,564,867 shares
Ownership: 9.9%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 18:30:15 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (4)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
RA Capital Management, L.P.	9.9%	4,564,867	4,564,867	/s/ Peter Kolchinsky	By Peter Kolchinsky, Authorized Signatory
Peter Kolchinsky	9.9%	4,564,867	4,564,867	/s/ Peter Kolchinsky	Peter Kolchinsky
Rajeev Shah	9.9%	4,564,867	4,564,867	/s/ Rajeev Shah	Rajeev Shah
RA Capital Healthcare Fund, L.P.	9.9%	4,564,867	4,564,867	/s/ Peter Kolchinsky	By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager